Bio-Gene Technology Limited (BGT.AX)

AUD 0.04

(0.0%)

Total Debt Summary of Bio-Gene Technology Limited

  • Bio-Gene Technology Limited's latest annual total debt in 2024 was - AUD , down 0.0% from previous year.
  • Bio-Gene Technology Limited's latest quarterly total debt in 2024 FY was - AUD , down 0.0% from previous quarter.
  • Bio-Gene Technology Limited reported annual total debt of - AUD in 2023, down 0.0% from previous year.
  • Bio-Gene Technology Limited reported annual total debt of - AUD in 2022, down 0.0% from previous year.
  • Bio-Gene Technology Limited reported quarterly total debt of - AUD for 2024 Q2, down 0.0% from previous quarter.
  • Bio-Gene Technology Limited reported quarterly total debt of - AUD for 2024 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of Bio-Gene Technology Limited (2024 - 2014)

Historical Annual Total Debt of Bio-Gene Technology Limited (2024 - 2014)

Year Total Debt Total Debt Growth
2024 - AUD 0.0%
2023 - AUD 0.0%
2022 - AUD 0.0%
2021 - AUD -100.0%
2020 11.66 Thousand AUD 0.0%
2019 - AUD 0.0%
2018 - AUD -100.0%
2017 150 Thousand AUD 0.0%
2016 - AUD 0.0%
2015 - AUD 0.0%
2014 - AUD 0.0%

Peer Total Debt Comparison of Bio-Gene Technology Limited

Name Total Debt Total Debt Difference
EZZ Life Science Holdings Limited 123.85 Thousand AUD 100.0%
Anatara Lifesciences Ltd - AUD NaN%
Zelira Therapeutics Limited 5.65 Million AUD 100.0%
Biome Australia Limited 1.3 Million AUD 100.0%
Patrys Limited - AUD NaN%
Orthocell Limited 689.69 Thousand AUD 100.0%
Imugene Limited 1.54 Million AUD 100.0%
Noxopharm Limited - AUD NaN%
PYC Therapeutics Limited 1.11 Million AUD 100.0%
Chimeric Therapeutics Limited - AUD NaN%
Prescient Therapeutics Limited 330.48 Thousand AUD 100.0%
Proteomics International Laboratories Limited 316.39 Thousand AUD 100.0%
Cynata Therapeutics Limited - AUD NaN%
CSL Limited 18.24 Billion AUD 100.0%
Arovella Therapeutics Limited - AUD NaN%
Clinuvel Pharmaceuticals Limited 879.78 Thousand AUD 100.0%
Starpharma Holdings Limited 3.52 Million AUD 100.0%
Nanollose Limited 42.53 Thousand AUD 100.0%
Memphasys Limited 4.41 Million AUD 100.0%
Invex Therapeutics Ltd - AUD NaN%
NeuroScientific Biopharmaceuticals Limited - AUD NaN%
Amplia Therapeutics Limited 1.56 Million AUD 100.0%
Botanix Pharmaceuticals Limited - AUD NaN%
Island Pharmaceuticals Limited 421.96 Thousand AUD 100.0%
Race Oncology Limited - AUD NaN%
Nyrada Inc. - AUD NaN%
Telix Pharmaceuticals Limited 17.44 Million AUD 100.0%
Dimerix Limited 149.68 Thousand AUD 100.0%
PharmAust Limited - AUD NaN%
Immutep Limited 1.22 Million AUD 100.0%
Clarity Pharmaceuticals Ltd - AUD NaN%
Alterity Therapeutics Limited 159.04 Thousand AUD 100.0%
BTC Health Limited - AUD NaN%
Acrux Limited 1.48 Million AUD 100.0%
Neuren Pharmaceuticals Limited - AUD NaN%
Biotron Limited 7130.00 AUD 100.0%
Tissue Repair Ltd - AUD NaN%
AdAlta Limited 2.49 Million AUD 100.0%
Radiopharm Theranostics Limited - AUD NaN%
Hexima Limited - AUD NaN%
AnteoTech Limited 23.59 Thousand AUD 100.0%
Paradigm Biopharmaceuticals Limited 239.33 Thousand AUD 100.0%
Recce Pharmaceuticals Ltd 811.19 Thousand AUD 100.0%
Avecho Biotechnology Limited 175.15 Thousand AUD 100.0%
Actinogen Medical Limited 319.06 Thousand AUD 100.0%
Immuron Limited 173.49 Thousand AUD 100.0%
Argenica Therapeutics Limited - AUD NaN%